[{"address1": "455 Mission Bay Boulevard South", "city": "San Francisco", "state": "CA", "zip": "94158", "country": "United States", "phone": "415 482 5300", "fax": "415 339 5300", "website": "https://www.nektar.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally. It develops NKTR-358, a regulatory T (Treg) cell stimulator designed to address the imbalance in the immune system underlying autoimmune disorders and chronic inflammatory conditions; PEG-CSF1, a polyethylene glycol (PEG) modified hematopoietic colony stimulating factor protein that is engineered to selectively modulate resolution processes of inflammation and has applications in a number of therapeutic indications, including acute and chronic inflammation; Tumor necrosis factor (TNF) receptor type II (TNFR2) agonist asset is a bivalent antibody molecule used to selectively stimulate TNFR2 receptor activity, without modulation of the TNFR1 signaling; and NKTR-255, an IL-15 receptor agonist designed to boost the immune system's natural ability to fight cancer. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. The company was incorporated in 1990 and is headquartered in San Francisco, California.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Mr. Howard W. Robin", "age": 71, "title": "CEO, President & Director", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 2166571, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra A. Gardiner", "age": 58, "title": "CFO and Principal Financial & Accounting Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 460850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark A. Wilson J.D.", "age": 52, "title": "Senior VP, Chief Legal Officer & Secretary", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 898297, "exercisedValue": 0, "unexercisedValue": 46583}, {"maxAge": 1, "name": "Dr. Jonathan  Zalevsky Ph.D.", "age": 49, "title": "Senior VP and Chief Research & Development Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 1151200, "exercisedValue": 0, "unexercisedValue": 35833}, {"maxAge": 1, "name": "Mr. Jason  Barnard", "title": "Chief Accounting Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Bacci", "title": "Chief People Officer and Head of Quality & Facilities", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer  Ruddock", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brian L. Kotzin M.D.", "age": 75, "title": "Interim Chief Medical Officer", "yearBorn": 1949, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 2, "overallRisk": 5, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.nektar.com/", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 21.75, "open": 22.59, "dayLow": 22.01, "dayHigh": 23.98, "regularMarketPreviousClose": 21.75, "regularMarketOpen": 22.59, "regularMarketDayLow": 22.01, "regularMarketDayHigh": 23.98, "payoutRatio": 0.0, "beta": 0.964, "forwardPE": -29.948051, "volume": 900584, "regularMarketVolume": 900584, "averageVolume": 1862273, "averageVolume10days": 550340, "averageDailyVolume10Day": 550340, "bid": 22.87, "ask": 23.44, "bidSize": 5, "askSize": 5, "marketCap": 398949536, "fiftyTwoWeekLow": 6.45, "fiftyTwoWeekHigh": 37.38, "priceToSalesTrailing12Months": 4.5725923, "fiftyDayAverage": 19.435, "twoHundredDayAverage": 14.9935, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 237877344, "profitMargins": -1.5248599, "floatShares": 10698480, "sharesOutstanding": 17300500, "sharesShort": 1164456, "sharesShortPriorMonth": 595786, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0673, "heldPercentInsiders": 0.00961, "heldPercentInstitutions": 0.61838, "shortRatio": 0.24, "shortPercentOfFloat": 0.0688, "impliedSharesOutstanding": 17857300, "bookValue": 4.904, "priceToBook": 4.702284, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -133041000, "trailingEps": -9.45, "forwardEps": -0.77, "lastSplitFactor": "1:15", "lastSplitDate": 1749427200, "enterpriseToRevenue": 2.726, "enterpriseToEbitda": -1.741, "52WeekChange": 0.38498497, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 23.06, "targetHighPrice": 120.0, "targetLowPrice": 69.0, "targetMeanPrice": 96.16667, "targetMedianPrice": 99.0, "recommendationMean": 1.875, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 218632000, "totalCashPerShare": 17.622, "ebitda": -136622000, "totalDebt": 186659008, "quickRatio": 3.107, "currentRatio": 3.241, "totalRevenue": 87248000, "debtToEquity": 1358.706, "revenuePerShare": 6.241, "returnOnAssets": -0.26798, "returnOnEquity": -1.89459, "grossProfits": 65096000, "freeCashflow": -47842876, "operatingCashflow": -176874000, "revenueGrowth": -0.517, "grossMargins": 0.7461, "ebitdaMargins": -1.5659, "operatingMargins": -4.24149, "financialCurrency": "USD", "symbol": "NKTR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_29929", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 6.02299, "regularMarketPrice": 23.06, "epsTrailingTwelveMonths": -9.45, "epsForward": -0.77, "epsCurrentYear": -9.84, "priceEpsCurrentYear": -2.3434958, "fiftyDayAverageChange": 3.625, "fiftyDayAverageChangePercent": 0.18651918, "twoHundredDayAverageChange": 8.0665, "twoHundredDayAverageChangePercent": 0.5379998, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.9 - Buy", "cryptoTradeable": false, "postMarketChangePercent": 0.607118, "postMarketPrice": 23.2, "postMarketChange": 0.140001, "regularMarketChange": 1.31, "regularMarketDayRange": "22.01 - 23.98", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1862273, "fiftyTwoWeekLowChange": 16.61, "fiftyTwoWeekLowChangePercent": 2.575194, "fiftyTwoWeekRange": "6.45 - 37.38", "fiftyTwoWeekHighChange": -14.320002, "fiftyTwoWeekHighChangePercent": -0.38309258, "fiftyTwoWeekChangePercent": 38.498497, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1754600400, "earningsCallTimestampEnd": 1754600400, "isEarningsDateEstimate": true, "shortName": "Nektar Therapeutics", "longName": "Nektar Therapeutics", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1754695276, "regularMarketTime": 1754683200, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 767971800000, "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]